These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 3403004)

  • 1. Dopamine receptor binding activity of anti-parkinsonian active piperazino derivatives.
    Srivastava VK; Palit G; Agarwal AK; Shanker K
    Indian J Exp Biol; 1988 Jan; 26(1):15-7. PubMed ID: 3403004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
    Jiang DH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):209-13. PubMed ID: 4075909
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiparkinsonian activity and dopamine receptor binding studies of imidazolone derivatives.
    Naithani PK; Srivastava VK; Saxena AK; Barthwal JP; Gupta TK; Shanker K
    Indian J Exp Biol; 1990 Dec; 28(12):1145-8. PubMed ID: 2099330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopamine agonists in the therapy of parkinson syndrome].
    Kapfhammer HP; Rüther E
    Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
    [No Abstract]   [Full Text] [Related]  

  • 6. Seasonal variations in the endogenous rhythm of dopamine receptor binding in rat striatum.
    Naber D; Wirz-Justice A; Kafka MS; Tobler I; Borbély AA
    Biol Psychiatry; 1981 Sep; 16(9):831-5. PubMed ID: 7295843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
    Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S; Ohoyama K; Nagase H; Okada M
    Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 10. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
    Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
    Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.
    Bøgesø KP
    J Med Chem; 1983 Jul; 26(7):935-47. PubMed ID: 6134833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced alterations in neurotransmitter receptor binding and function.
    Enna SJ; Ferkany JW; Strong R
    Adv Biochem Psychopharmacol; 1980; 21():253-63. PubMed ID: 6246740
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging dopamine receptors in the rat striatum with the MicroPET R4: kinetic analysis of [11C]raclopride binding using graphical methods.
    Alexoff DL; Vaska P; Logan J
    Methods Enzymol; 2004; 385():213-28. PubMed ID: 15130741
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
    Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E
    Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 17. 1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Fornaretto MG; Caccia C; McArthur RA
    J Med Chem; 1996 Aug; 39(16):3195-202. PubMed ID: 8759642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and localization of the recognition binding subunit of the D1 dopamine receptor.
    Tanaka C; Kuno T; Mita T; Ishibe T
    Adv Biochem Psychopharmacol; 1983; 36():135-45. PubMed ID: 6858751
    [No Abstract]   [Full Text] [Related]  

  • 19. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.